Vical (VICL)

Add to Watchlists
Create an Alert
1.20 -0.03  -2.44% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
VICL Price Chart
View All Events

VICL Events

Date Type Description
Feb 12 Misc Q4 2013 Vical Conference Call
Feb 12 Earnings Q4 2013 Vical Earnings Results. Estimate: -0.08.
Oct 31 Misc Vical Announces News Release and Conference Call Schedule for Third Quarter Conference Call
Oct 31 Earnings Vical Announces News Release and Conference Call Schedule for Third Quarter Release. Estimate: -0.11.
Aug 01 Misc Vical Announces News Release and Conference Call Schedule for Second Quarter 2013 Financial Results
Aug 01 Earnings Second Quarter 2013 Financial Results. Estimate: -0.11.
May 23 Misc AGM Event for Vical, Inc.
May 09 Earnings Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results. Estimate: -0.09.
May 09 Misc Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results
View All Performance Charts

VICL Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Vical is down 68.83% over the last year vs S&P 500 Total Return up 23.54%, Astellas Pharma down 1.15%, and Biogen Idec up 42.37%.

Get Quote for
Advertisement

Portfolio Strategies Featuring VICL

Did Vical make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VICL Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Vical Incorporated researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VICL 1.20 -0.03 -2.44% 104.13M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.